Olfactory deficits and cardiac 123I-MIBG in Parkinson's disease related to the LRRK2 R1441G and G2019S mutations. - Wikidata - wikimedia - TriplyDB

Olfactory deficits and cardiac 123I-MIBG in Parkinson's disease related to the LRRK2 R1441G and G2019S mutations.

Olfactory deficits and cardiac 123I-MIBG in Parkinson's disease related to the LRRK2 R1441G and G2019S mutations.

http://www.wikidata.org/entity/Q46521682

about

Identification of a Japanese family with LRRK2 p.R1441G-related Parkinson's disease Cardiac sympathetic denervation in 6-OHDA-treated nonhuman primates.Elevated levels of cerebrospinal fluid α-synuclein oligomers in healthy asymptomatic LRRK2 mutation carriers.Nonmotor symptoms in LRRK2 G2019S associated Parkinson's disease Non-motor and motor features in LRRK2 transgenic mice.Sleep Disorders in Parkinsonian and Nonparkinsonian LRRK2 Mutation Carriers Olfaction in Parkinson's disease and related disorders.REM sleep behavior disorder, as assessed by questionnaire, in G2019S LRRK2 mutation PD and carriers.Drosophila Mutant Model of Parkinson's Disease Revealed an Unexpected Olfactory Performance: Morphofunctional Evidences.LRRK2: cause, risk, and mechanism.Modeling and imaging cardiac sympathetic neurodegeneration in Parkinson's disease.Olfactory bulb involvement in neurodegenerative diseases.Neurogenetic disorders in the Basque population.(123)I-Metaiodobenzylguanidine Myocardial Scintigraphy in Lewy Body-Related Disorders: A Literature Review.The underlying mechanism of prodromal PD: insights from the parasympathetic nervous system and the olfactory system The prodromal phase of leucine-rich repeat kinase 2-associated Parkinson disease: Clinical and imaging Studies.Motor and nonmotor heterogeneity of LRRK2-related and idiopathic Parkinson's disease.Heart rate variability in leucine-rich repeat kinase 2-associated Parkinson's disease.Olfactory Dysfunction in Parkinson's Disease Patients with the LRRK2 G2385R Variant.Olfactory dysfunction in sporadic Parkinson's Disease and LRRK2 carriers.VEGF Signaling in Neurological Disorders.DAT imaging and clinical biomarkers in relatives at genetic risk for LRRK2 R1441G Parkinson's disease.Genetic fine-mapping of the Iowan SNCA gene triplication in a patient with Parkinson's disease.

P2860

Q30587398-132F4B36-FC3F-4EBA-8255-8BF87FA87934 Q34061568-CFCCE8FC-190A-42DE-8DE8-208EBD283363 Q34242682-BB3391D3-C9E0-4F02-A89E-6BB1632B192E Q34361735-F9634FDB-888B-4B06-BAE9-0DF446B9E0F2 Q34922393-E06DE802-1056-4F89-8378-50FB1EAAEC0A Q35692655-163A1D87-C733-4D71-A3AA-A3921D4033FD Q36193915-436C8493-EA86-4F4B-B40E-6F6F4CDAE1E0 Q36470291-4E75B507-5CA0-473B-A402-51FD4BE14CFE Q37246534-8C8DD9CB-EF67-40FD-878B-539868C8C11E Q37635000-819DDEE3-860C-4BC1-9395-A21780AB5A44 Q37711062-A87C84AA-9951-424B-B8AC-4938ABA7E1C0 Q38189727-2730494F-22EB-413C-AE19-F14EB1D76EF6 Q38273952-B412FC44-8483-430D-90FB-352028D82BA4 Q38531996-0192E230-0077-411F-BFE9-2E236E7764FF Q38752945-873BD797-FC9B-44A8-ADD7-EA860175FC42 Q38859352-9DBEC281-8901-487E-8C48-4B7EB082A620 Q39841718-4A6F52B6-66CC-4441-BE5A-E47703E67EB9 Q46341748-2FD0CC24-1460-4B50-8835-8E373A2CAE00 Q47139141-C3D02551-AD31-4A47-850A-3496AE930E20 Q47797902-CF22CF0D-FF00-4964-9D6F-339EFFB29802 Q47860045-29CA935D-3CF5-41FB-8F6D-5B476D5C8BA9 Q47907932-39073FBD-72DA-4D99-A918-2B321F5C9D86 Q55209699-A7FC5C60-3372-4A12-B7BF-FB24D86873EE

P2860

Olfactory deficits and cardiac 123I-MIBG in Parkinson's disease related to the LRRK2 R1441G and G2019S mutations.

http://www.wikidata.org/entity/Q46521682

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

Olfactory deficits and cardiac ...... 2 R1441G and G2019S mutations.

@en

Olfactory deficits and cardiac ...... 2 R1441G and G2019S mutations.

@nl

type

label

Olfactory deficits and cardiac ...... 2 R1441G and G2019S mutations.

@en

Olfactory deficits and cardiac ...... 2 R1441G and G2019S mutations.

@nl

prefLabel

Olfactory deficits and cardiac ...... 2 R1441G and G2019S mutations.

@en

Olfactory deficits and cardiac ...... 2 R1441G and G2019S mutations.

@nl

P1433

Q46521682-0C5231BE-E6C7-4784-8B7A-A0E069915724

P1476

Q46521682-B4EB9A2C-E002-42D7-A9BC-6A8AA6829E97

P2093

Q46521682-17DB57CA-6189-45C4-A9FF-71D15356BB84

Q46521682-467E7067-BB3A-4D31-BB33-475906C2CA39

Q46521682-5ABDD9C0-3617-41C7-92C9-750CC22B5762

Q46521682-61E7C080-FD60-417B-B3CD-52056CE3E652

Q46521682-729F42E9-BE0A-4D50-9BC1-C33C4B65F782

Q46521682-88C9B255-45B9-43CA-8000-B02102B9DAFF

Q46521682-D434464D-A03B-430D-B09F-CD5D24A32EA0

Q46521682-DC3E5810-2187-44EB-A889-9AB8604837B6

Q46521682-E9D37637-8653-4112-A3BF-1D35B6CA692F

Q46521682-F74A07FE-A843-458F-BA99-D2A80D4B5CE6

P2860

Q46521682-15AAD0AE-2613-4B2A-B5CD-836961B7E1E7

Q46521682-1CD125C4-8910-4116-9121-B6F9E40D8696

Q46521682-25D3CFF9-C9E4-4028-98E4-602B51D96A72

Q46521682-2A41415C-3B6B-4B95-8750-057C3BDE211D

Q46521682-2D6D35E4-B88E-4DA6-99CB-B141F651D607

Q46521682-30DBD856-541C-421D-8D1B-25A0784E9690

Q46521682-38479573-E932-4677-8C68-D53AC281E60E

Q46521682-3D2CBF05-EDD4-453A-9777-2D4DE8B08D0E

Q46521682-41BA0C2B-0999-47E5-AEE2-F8844A5BDADF

Q46521682-475FE2F6-C9A8-4300-833B-28574D3F0233

P304

Q46521682-A9D15CBA-2A78-4E07-A7C4-4A76C7F6DBF3

P31

Q46521682-59B266F1-ED35-4F92-B1C6-4BA77D9651CC

P356

Q46521682-1013FE2F-AA9C-48FF-A595-A3C18F0A5B8F

P407

Q46521682-05486479-06BD-4D2A-B940-A82D6DABB96E

P433

Q46521682-5D5A1D2A-0024-4B43-B593-83E27178D72F

P478

Q46521682-B6305F6A-6BF3-4CA3-B633-3C956DEAF968

P577

Q46521682-E7233776-D1C8-4AB3-916C-82A37DA4BCDF

P5875

Q46521682-32450D6D-4F94-4773-A711-221E5C03A1F5

P698

Q46521682-23A44BFD-ED1A-40CB-ABB7-D0BD52E1A6E8

P356

P1433

Movement Disorders

P1476

Olfactory deficits and cardiac ...... 2 R1441G and G2019S mutations.

@en

P2093

Adolfo López de Munain

http://www.w3.org/2001/XMLSchema#string

Ainhoa Alzualde

http://www.w3.org/2001/XMLSchema#string

Alberto Bergareche

http://www.w3.org/2001/XMLSchema#string

Ana Gorostidi

http://www.w3.org/2001/XMLSchema#string

Estibaliz Goyenechea

http://www.w3.org/2001/XMLSchema#string

Fermín Moreno

http://www.w3.org/2001/XMLSchema#string

Francisco Rodríguez

http://www.w3.org/2001/XMLSchema#string

Javier Ruiz-Martínez

http://www.w3.org/2001/XMLSchema#string

José F Martí Massó

http://www.w3.org/2001/XMLSchema#string

Juan José Poza

http://www.w3.org/2001/XMLSchema#string

P2860

Staging of brain pathology related to sporadic Parkinson's disease

Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease

A clinical role for [(123)I]MIBG myocardial scintigraphy in the distinction between dementia of the Alzheimer's-type and dementia with Lewy bodies

Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study

Loss of olfaction in de novo and treated Parkinson's disease: possible implications for early diagnosis.

Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data.

Hyposmia in G2019S LRRK2-related parkinsonism: clinical and pathologic data.

Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations.

Diagnostic criteria for Parkinson disease.

The role of cardiac metaiodobenzylguanidine uptake in the differential diagnosis of parkinsonian syndromes.

P304

2026-2031

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MDS.23773

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51164669

http://www.w3.org/2001/XMLSchema#string

P698

21611983

http://www.w3.org/2001/XMLSchema#string